📰 Jonathan Gdanski News
Page 2 - Jonathan Gdanski News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jonathan Gdanski. Real-time updates on events, politics, business and more.
March 2, 2022
The FDA now cautions against using a specific lot of Abbott Nutrition's Similac PM 60/40 after a second infant dies. Abbott voluntarily recalled the specialty product on Monday.
March 1, 2022
The FDA now cautions against using a specific lot of Abbott Nutrition's Similac PM 60/40 after a second infant dies. Abbott voluntarily recalled the specialty product on Monday.
March 1, 2022
The FDA now cautions against using a specific lot of Abbott Nutrition's Similac PM 60/40 after a second infant dies. Abbott voluntarily recalled the specialty product on Monday.
March 1, 2022
The FDA now cautions against using a specific lot of Abbott Nutrition's Similac PM 60/40 after a second infant dies. Abbott voluntarily recalled the specialty product on Monday.
March 1, 2022
The FDA now cautions against using a specific lot of Abbott Nutrition's Similac PM 60/40 after a second infant dies. Abbott voluntarily recalled the specialty product on Monday.
March 1, 2022
The FDA now cautions against using a specific lot of Abbott Nutrition's Similac PM 60/40 after a second infant dies. Abbott voluntarily recalled the specialty product on Monday.
March 1, 2022
The FDA now cautions against using a specific lot of Abbott Nutrition's Similac PM 60/40 after a second infant dies. Abbott voluntarily recalled the specialty product on Monday.
March 1, 2022
The FDA now cautions against using a specific lot of Abbott Nutrition's Similac PM 60/40 after a second infant dies. Abbott voluntarily recalled the specialty product on Monday.
March 1, 2022
The FDA now cautions against using a specific lot of Abbott Nutrition's Similac PM 60/40 after a second infant dies. Abbott voluntarily recalled the specialty product on Monday.
February 22, 2022
/PRNewswire/ -- Schlesinger Law Offices, P.A. has filed a nationwide and Florida class action lawsuit against Abbott Laboratories, alleging that the company...